CONFERENCE UPDATE: EPA 2023
Esketamine NS induces higher remission and response rates in treatmentresistant depression patients: The ESCAPE-TRD trial
29 Jun 2023
Related Articles
CONFERENCE UPDATE: EPA 2023
Esketamine NS induces higher remission and response rates in treatmentresistant depression patients: The ESCAPE-TRD trial